Skip to content

TIGRIS Vascular Stent PHA061002ARecalls & reported problems

W. L. Gore & Associates, Inc. · Class 3 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00733132636297), received between Nov 16, 2018 and Nov 16, 2018 — classified as 1 malfunction.

The most frequently reported specific device problem is “Activation Failure” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Activation Failure1

Patient problems

  • Occlusion1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionNov 16, 2018Activation Failure; Activation Failure

    THE FOLLOWING WAS REPORTED TO GORE: THE PATIENT PRESENTED FOR RELINING OF A BARE METAL STENT BEHIND THE KNEE. THE GORE® TIGRIS® VASCULAR STENT WOULD NOT DEPLOY ON THE .018 GUIDEWIRE. WHEN THE DOCTOR ATTEMPTED TO REMOVE THE PARTIALLY DEPLOYED DEVICE, THE WIRE ALSO CAME OUT.

    Patient problems: Occlusion

    MAUDE report 8079122 ↗

Other Stent, Superficial Femoral Artery devices

All Stent, Superficial Femoral Artery devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page